International developed-market equities sit at the center of portfolio debates today, as investors weigh stretched U.S. valuations against the relative discounts available in Europe and Japan. The EFA and IDEV exchange-traded funds (ETFs) are natural points of comparison because both are issued by iShares and both offer broad developed-market exposure outside the United States. They are not rivals in strategy but alternatives in scope: EFA is the long-established benchmark for Europe, Australasia, and the Far East (EAFE), while IDEV is a newer, lower-cost, more complete take on the same opportunity set. Understanding their structural differences helps investors decide how much breadth—and how much fee—they actually need.
The iShares MSCI EAFE ETF (EFA) seeks to track the MSCI EAFE Index, a free-float-adjusted, market-capitalization-weighted benchmark of large- and mid-cap equities in developed markets outside the U.S. and Canada. It is a passively managed, physically replicated fund that holds roughly 700 securities across 21 developed countries, with the largest country weights in Japan, the United Kingdom, and Switzerland.
Top holdings are dominated by European multinationals, including ASML, AstraZeneca, Novartis, Roche, Shell, HSBC, Nestlé, Siemens, SAP, and Toyota Motor. Sector allocation tilts toward Financials (roughly 24–25%), Industrials (about 19%), Information Technology (around 11%), and Health Care (about 10%). The fund charges a net expense ratio of 0.32% and is one of the most liquid and widely traded international ETFs, with a long track record and deep secondary-market liquidity.
The iShares Core MSCI International Developed Markets ETF (IDEV) seeks to track the MSCI World ex USA Investable Market Index, a free-float-adjusted, market-cap-weighted index spanning large-, mid-, and small-cap developed-market equities outside the U.S. Crucially, unlike EFA, it includes Canada and extends down the market-cap spectrum into small caps.
The fund holds roughly 2,200–2,300 securities, with the largest country exposures in the Eurozone, Japan, the United Kingdom, and Canada. Top holdings include ASML, AstraZeneca, Novartis, Roche, HSBC, Shell, Nestlé, Royal Bank of Canada, Siemens, and Toyota Motor. Sector allocation is comparable to EFA but slightly more balanced, led by Financials (about 24%), Industrials (about 19%), Health Care (around 9%), and Information Technology (about 9%). Its defining feature is cost: a net expense ratio of just 0.04%, positioning it as a core, low-fee building block.
Both funds operate in the same macro environment, where international developed markets have benefited from a weaker dollar, attractive relative valuations, and robust shareholder-return programs among large European and Japanese companies. The heavy Financials weighting in each fund makes them sensitive to interest-rate trajectories, while the Industrials and Materials exposure links them to global trade and capital-expenditure cycles. Japan remains a pivotal swing factor, with corporate-governance reforms and a weak yen supporting earnings at export-heavy names. Key risks include a potential global slowdown, currency volatility, geopolitical tension in Europe, and sector concentration in banks and cyclical industrials.
Across recent weeks and months, the two funds have generally moved in tandem, since they share a common core of large developed-market holdings. However, relative positioning differs in meaningful ways. IDEV's inclusion of Canada and small caps has given it modestly different return drivers, adding exposure to Canadian financials and energy-linked names that EFA excludes. EFA, by contrast, carries a slightly heavier weight to its largest European positions and tends to exhibit marginally higher single-name concentration. In recent market cycles, both have tracked the broader rotation toward value-oriented international equities, but IDEV's lower cost and wider net have helped it compound the same underlying exposure more efficiently over time.
Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is designed to surface trade ideas, trending names, breakout candidates, and market opportunities far more efficiently than manual screening. For investors comparing funds like EFA and IDEV, the AI Screener provides a data-driven way to evaluate relative positioning and momentum across the opportunity set.
Based on observable structural factors, Tickeron's AI would likely favor IDEV in this comparison. The fund offers materially lower cost (0.04% versus 0.32%), broader diversification across roughly three times as many holdings, and more complete developed-market coverage that includes Canada and small caps. These characteristics generally translate into greater risk dispersion and a higher probability of efficient long-term compounding. While EFA retains an edge in liquidity and historical familiarity, IDEV's cost efficiency, diversification profile, and trend-consistent exposure make it the stronger structural candidate for investors seeking broad international developed-market positioning.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The Moving Average Convergence Divergence (MACD) for EFA turned positive on October 15, 2026. Looking at past instances where EFA's MACD turned positive, the stock continued to rise in 38 of 44 cases over the following month. The odds of a continued upward trend are 86%.
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on EFA as a result. In 64 of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.
Following a +0.73% 3-day Advance, the price is estimated to grow further. Considering data from situations where EFA advanced for three days, in 260 of 314 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 44 of 60 cases where EFA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 73%.
EFA moved below its 50-day moving average on November 10, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EFA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
EFA broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for EFA entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Moving Average Convergence Divergence (MACD) for IDEV turned positive on November 09, 2026. Looking at past instances where IDEV's MACD turned positive, the stock continued to rise in 41 of 48 cases over the following month. The odds of a continued upward trend are 85%.
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on IDEV as a result. In 63 of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.
Following a +0.62% 3-day Advance, the price is estimated to grow further. Considering data from situations where IDEV advanced for three days, in 258 of 322 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 48 of 60 cases where IDEV's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 80%.
IDEV moved below its 50-day moving average on November 10, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IDEV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
IDEV broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for IDEV entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
| EFA | IDEV | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 2 days ago 73% | 2 days ago 80% |
| Momentum ODDS (%) | 2 days ago 79% | 2 days ago 80% |
| MACD ODDS (%) | 2 days ago 86% | 2 days ago 85% |
| TrendWeek ODDS (%) | 2 days ago 80% | 2 days ago 80% |
| TrendMonth ODDS (%) | 2 days ago 80% | 2 days ago 79% |
| Advances ODDS (%) | 14 days ago 83% | 14 days ago 80% |
| Declines ODDS (%) | 6 days ago 79% | 6 days ago 78% |
| BollingerBands ODDS (%) | 2 days ago 76% | 2 days ago 71% |
| Aroon ODDS (%) | 2 days ago 78% | 2 days ago 76% |
A.I.dvisor indicates that over the last year, EFA has been closely correlated with STM. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if EFA jumps, then STM could also see price increases.
A.I.dvisor indicates that over the last year, IDEV has been closely correlated with SAN. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if IDEV jumps, then SAN could also see price increases.
| Ticker / NAME | Correlation To IDEV | 1D Price Change % | ||
|---|---|---|---|---|
| IDEV | 100% | -0.65% | ||
| SAN - IDEV | 74% Closely correlated | +0.80% | ||
| BBVA - IDEV | 74% Closely correlated | +0.19% | ||
| NWG - IDEV | 70% Closely correlated | -1.68% | ||
| BHP - IDEV | 69% Closely correlated | -2.10% | ||
| BMO - IDEV | 68% Closely correlated | -0.80% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PAYM | 24.61 | 0.31 | +1.27% |
| TrueShares S&P Autocallable Defensive Income ETF (PAYM) | |||
| FEBM | 31.78 | 0.01 | +0.04% |
| FT Vest US Equity Max Buffer ETF-February (FEBM) | |||
| FDRS | 23.94 | N/A | N/A |
| Founder-Led ETF | |||
| AKRE | 60.27 | -0.03 | -0.05% |
| Akre Focus ETF (AKRE) | |||
| NUKZ | 56.28 | -0.74 | -1.30% |
| Range Nuclear Renaissance Index ETF (NUKZ) | |||